Healthcare Services

Increasing viral infections are fueling growth in the common warts market

April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Common Warts Market Expected To Scale Between 2026 And 2030?

The common warts market size has experienced robust growth in recent years. It is anticipated to expand from $2.25 billion in 2025 to $2.38 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.8%. This historical growth can be linked to the increasing prevalence of hpv infections, widespread use of cryotherapy treatments, availability of topical salicylic acid products, growth of dermatology clinics, and improved awareness of skin health.

The common warts market is anticipated to experience robust expansion over the forthcoming years. It is projected to attain a valuation of $2.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.6%. This expected growth during the forecast period is driven by factors such as the increasing demand for non-invasive dermatological treatments, a rising emphasis on cosmetic dermatology solutions, the widening array of homecare dermatology products, the growing uptake of laser-based therapies, and enhanced investment in immunomodulatory treatments. Noteworthy trends predicted for this period encompass advancements in minimally invasive wart removal techniques, a rising embrace of combination therapy approaches, greater availability of over-the-counter treatments, the expanding utilization of immunotherapy-based topical applications, and an increase in home-based treatment options.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

What Major Factors Are Driving The Common Warts Market Forward?

The common warts market is anticipated to expand due to the rising occurrence of viral infections. Viral infections are diseases that occur when viruses infiltrate, reproduce, and disseminate throughout the body, impacting cells and immune system functions. Factors such as globalization, climate change, urbanization, deforestation, and compromised immune systems contribute to this growing prevalence of viral infections. Treatment for common warts focuses on the human papillomavirus (HPV) that causes them, offering crucial assistance to individuals with viral infections by limiting viral transmission, easing pain, encouraging recovery, and thereby averting issues like secondary infections or scarring, ultimately enhancing patients’ quality of life. For example, data from the US-based government agency, the Centers for Disease Control and Prevention, indicates that in 2024, the percentage of PCR-confirmed varicella cases in 2022 climbed by 62%, moving from 29% to 47% in the previous five years. Additionally, the US-based health organization, the National Foundation for Infectious Diseases, reported in January 2023 that approximately 14 million new HPV infections are diagnosed each year in the United States. Consequently, the expanding occurrence of viral infections is fueling the expansion of the common warts market.

How Is Segmentation Applied In The Common Warts Market Segment Analysis?

The common warts market covered in this report is segmented –

1) By Treatment Method: Cryotherapy, Laser Treatment, Electrosurgery, Topical Medications

2) By Patient Demographics: Children, Adults, Elderly

3) By Disease Stage: Initial Stage, Moderate Stage, Severe Stage

4) By End User: Hospitals, Dermatology Clinics, Home Care

Subsegments:

1) By Cryotherapy: Liquid Nitrogen Therapy, Carbon Dioxide Therapy

2) By Laser Treatment: Pulsed-Dye Laser Therapy, Carbon Dioxide (CO2) Laser Therapy

3) By Electrosurgery: Curettage And Electrosurgical Removal, High-Frequency Electrosurgical Ablation

4) By Topical Medications: Salicylic Acid-Based Therapy, Immunotherapy-Based Topicals, Retinoid-Based Therapy

Which Trends Are Impacting The Progress Of The Common Warts Market?

Leading entities within the common warts market are prioritizing the advancement of innovative treatments, such as dermatological therapies, to address the increasing demand for effective and accessible solutions. This focus aims to enhance patient outcomes and broaden their footprint within the dermatology sector. Dermatological therapies involve treatments for various skin conditions, including infections, inflammations, and disorders. For example, in May 2024, Verrica Pharmaceuticals, a US-based pharmaceutical company, formed a license agreement with Torii Pharmaceutical Co. Ltd., a Japan-based pharmaceutical company. This collaboration is designed to fund a global Phase 3 clinical trial for YCANTH, a treatment specifically for common warts. The agreement provides support for the late-stage development of YCANTH, thereby expanding its potential reach worldwide. Torii Pharmaceuticals is committed to contributing financial resources to further this study. This joint effort is expected to bolster the dermatology portfolios and international market presence for both companies.

Who Are The Companies Participating In The Common Warts Market Environment?

Major companies operating in the common warts market are GSK plc, Perrigo Company plc, Holland & Barrett International Limited, Prestige Consumer Healthcare Inc., Novan Inc., Aclaris Therapeutics Inc., Verrica Pharmaceuticals Inc., Scholl’s Wellness Company, Naturasil, Bausch Health Companies Inc., Viatris Inc., Sanofi S.A., Pfizer Inc., Bayer AG, Novartis AG, Dr Reddy’s Laboratories Ltd, Cipla Inc, Taro Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, AIM ImmunoTech Inc, Phio Pharmaceuticals Corp, Euro Vital Pharma GmbH, Koninklijke Utermöhlen NV, Lumenis Be Ltd, Almirall S.A, Daiichi Sankyo Company Ltd

Get The Full Common Warts Market Report:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

Which Region Is The Leading Market For The Common Warts Market?

North America was the largest region in the common warts market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the common warts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Common Warts Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

Browse Through More Reports Similar to the Global Common Warts Market 2026, By The Business Research Company

Specialty Malt Market Report 2026

https://www.thebusinessresearchcompany.com/report/specialty-malt-global-market-report

Warts Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/warts-therapeutics-global-market-report

Asphalt Shingles Market Report 2026

https://www.thebusinessresearchcompany.com/report/asphalt-shingles-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795